BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35981899)

  • 1. Prospective Phase II Trial of [
    Carlsen EA; Loft M; Loft A; Czyzewska D; Andreassen M; Langer SW; Knigge U; Kjaer A
    J Nucl Med; 2023 Feb; 64(2):252-259. PubMed ID: 35981899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-Human Study of [
    Clausen MM; Carlsen EA; Christensen C; Madsen J; Brandt-Larsen M; Klausen TL; Holm S; Loft A; Berthelsen AK; Kroman N; Knigge U; Kjaer A
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Phase II Trial of Prognostication by
    Carlsen EA; Loft M; Loft A; Berthelsen AK; Langer SW; Knigge U; Kjaer A
    J Nucl Med; 2022 Sep; 63(9):1371-1377. PubMed ID: 35058319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective head-to-head comparison of
    Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of α
    Grönman M; Tarkia M; Kiviniemi T; Halonen P; Kuivanen A; Savunen T; Tolvanen T; Teuho J; Käkelä M; Metsälä O; Pietilä M; Saukko P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Transl Med; 2017 Jun; 15(1):144. PubMed ID: 28629432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of Myocardial α
    Nammas W; Paunonen C; Teuho J; Siekkinen R; Luoto P; Käkelä M; Hietanen A; Viljanen T; Dietz M; Prior JO; Li XG; Roivainen A; Knuuti J; Saraste A
    J Nucl Med; 2024 Jan; 65(1):132-138. PubMed ID: 37973184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.
    Baum RP; Kulkarni HR; Müller D; Satz S; Danthi N; Kim YS; Brechbiel MW
    Cancer Biother Radiopharm; 2015 May; 30(4):152-9. PubMed ID: 25945808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity Comparison of
    Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X
    Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003
    [No Abstract]   [Full Text] [Related]  

  • 13. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-Head Comparison of
    Lin Z; Zhu W; Zhang J; Miao W; Yao S; Huo L
    J Nucl Med; 2023 Sep; 64(9):1406-1411. PubMed ID: 37474267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized, double-blind study to evaluate the diagnostic efficacy of
    Zhu W; Jia R; Yang Q; Cheng Y; Zhao H; Bai C; Xu J; Yao S; Huo L
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1613-1622. PubMed ID: 34874478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Evaluation of
    Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
    J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
    Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
    J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.
    Buchegger F; Viertl D; Baechler S; Dunet V; Kosinski M; Poitry-Yamate C; Rüegg C; Prior JO
    Nuklearmedizin; 2011; 50(6):225-33. PubMed ID: 21989840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [
    Lobeek D; Rijpkema M; Terry SYA; Molkenboer-Kuenen JDM; Joosten L; van Genugten EAJ; van Engen-van Grunsven ACH; Kaanders JHAM; Pegge SAH; Boerman OC; Weijs WLJ; Merkx MAW; van Herpen CML; Takes RP; Aarntzen EHJG; Oyen WJG
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2647-2655. PubMed ID: 32198613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between [
    Grönman M; Moisio O; Li XG; Toimela T; Huttala O; Heinonen T; Knuuti J; Roivainen A; Saraste A
    Mol Biol Rep; 2021 Jun; 48(6):5347-5353. PubMed ID: 34213709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.